Point72 (DIFC)’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Point72 (DIFC)’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-954	Closed	-$711	–	2154
2024 Q4	$711	Hold	954	–	–	﹤0.01%	1444
2024 Q3	$1.16K	Hold	954	–	–	﹤0.01%	1339
2024 Q2	$1.98K	Buy	954 +405	+74%	+$955	﹤0.01%	1394
2024 Q1	$2K	Buy	+549	New	+$2.1K	﹤0.01%	1396

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Point72 (DIFC)'s OMGA Position: Q1 2025 in Review

Point72 (DIFC) sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 954 shares — an estimated $711 sold.

Point72 (DIFC) first reported a position in OMGA in Q1 2024 and held it in 4 quarters. The position peaked at $2K in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Point72 (DIFC) reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Point72 (DIFC) sold 954 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $711.
Point72 (DIFC) first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
Point72 (DIFC)'s Omega Therapeutics, Inc. Common Stock position peaked at $2K in Q1 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Point72 (DIFC)'s 13F filing for Q1 2025, filed 15 May 2025.